L-glutamine
Conditionally essential amino acid with a single RCT signal for post-infectious diarrhoea-predominant IBS.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- The IBS-D trial used 5 g three times daily for 8 weeks
- Time to effect
- In the trial
- Safety
- Has documented cautions
Evidence ratings summarise published research on L-glutamine in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about L-glutamine
Interactions
Taking any medication?
Check L-glutamine against it.
Why
L-glutamine is the most abundant free amino acid in plasma and the preferred fuel for rapidly-dividing cells, including small-intestinal enterocytes and immune lymphocytes. The Zhou 2019 RCT in adults with post-infectious diarrhoea-predominant IBS and raised intestinal permeability reported a clinically meaningful symptom improvement versus placebo at 5 g three times daily for 8 weeks. It is a single trial in a narrow group, and the authors call for larger confirmatory trials.
How it works
Primary metabolic fuel for enterocytes, supports tight-junction integrity and mucosal barrier function. Substrate for glutathione synthesis. Anaplerotic in the TCA cycle during catabolic states (sepsis, burns, intensive training).
Expected onset · In the trial, symptoms were assessed after 8 weeks of use
How to take
Dosage
The IBS-D trial used 5 g three times daily for 8 weeks. No dose is established for other uses.
Timing
Between meals; powder dissolved in water
On the label
'L-glutamine' powder or capsules with stated grams. Pharmaceutical-grade is preferred for therapeutic doses.
Studied in
Adults with post-infectious IBS-D and raised intestinal permeability.
Safety
Evidence
Zhou 2019 Gut RCT (n=106 completers): in adults with post-infectious, diarrhoea-predominant IBS and raised intestinal permeability, glutamine 15 g/day for 8 weeks was followed by a clinically meaningful symptom-score drop in 79.6% versus 5.8% on placebo, with fewer daily bowel movements and lower permeability. This is a single trial in a narrow group; the authors called for larger trials.
GRADE certainty: Low — rated by Healicus using the GRADE method
Questions people ask
Does L-glutamine work?
Zhou 2019 Gut RCT (n=106 completers): in adults with post-infectious, diarrhoea-predominant IBS and raised intestinal permeability, glutamine 15 g/day for 8 weeks was followed by a clinically meaningful symptom-score drop in 79.6% versus 5.8% on placebo, with fewer daily bowel movements and lower permeability. This is a single trial in a narrow group; the authors called for larger trials. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is L-glutamine taken?
The IBS-D trial used 5 g three times daily for 8 weeks. No dose is established for other uses. Timing: Between meals; powder dissolved in water. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Avoid in cirrhosis and hepatic encephalopathy (ammonia loading risk). Caution in active cancer treatment. Coordinate with the oncology team. Pregnancy and breastfeeding data limited. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Zhou et al., Gut 2019, randomised placebo-controlled trial of dietary glutamine supplements for postinfectious IBS.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.